...a library also in the millions. In 2007, GlaxoSmithKline plc acquired Praecis Pharmaceuticals Inc. for $54.8 million. Praecis...
...molecule library that contained about 10 billion members. Wagner, who was EVP of research at Praecis...

...see BioCentury, June 11). GlaxoSmithKline plc obtained a similar DNA-encoded library technology when it acquired Praecis Pharmaceuticals Inc....
...Barry Morgan, VP of molecular discovery research at GSK and former VP of chemistry at Praecis...

...actually was requested by Praecis Pharmaceuticals Inc. to ensure that coverage was consistent with an FDA-mandated REMS. Praecis...

...marketed as Plenaxis in Germany to treat prostate cancer. In 2007, Speciality acquired abarelix from Praecis Pharmaceuticals Inc....

...request of the sponsor, Praecis Pharmaceuticals Inc. in an effort to overcome concerns about life-threatening adverse events. Praecis...

...screening Hired: Richard Wagner as president, CEO and a director, formerly EVP of research at Praecis Pharmaceuticals Inc....

...$120M in stock 12/18/06 Icos (A) Eli Lilly $27.12 $34.00 25% $2.3B in cash 12/21/06 Praecis...

...two more tranches for a total of $8.6 million by the end of this quarter. Praecis Pharmaceuticals Inc....

...undisclosed amount of cash and bought worldwide rights to prostate cancer drug Plenaxis abarelix from Praecis...

...LSE:GSK, GSK, London, U.K.) (see BioCentury, Jan. 1). Speciality European Pharma Ltd. , London, U.K. Praecis Pharmaceuticals Inc....